The filing follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccinesPending approval, Moderna’s updated COVID-19 vaccine will be available for fall vaccination with ample and timely supplyPreliminary clinical data show that the company’s XBB1.5 monovalent vaccine induces an immune response against viruses of the XBB lineageCAMBRIDGE…
Read More
About The Author
